Home
James Kihara, Principal Accounting Officer: Acadia Pharmaceuticals ACAD Sell · Filed 25/11/19
Trade details
- Type
- Insider sale
- Amount
- $96,749.96
- Shares · price
- 4,084 sh · $23.69 a share
- Held after
- 25,058 sh
- Trade date
- 25/11/18
- Filed
- 25/11/19
- Days to filing
- 1 days
Sold 14.0% of holdings
- Share of holding sold
- 14.0%
Acadia Pharmaceuticals trades, last 26 weeks
What else happened in Acadia Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/10/19~25/12/18James Kihara's recent trades
- James Kihara
Sell10b5-1 planAcadia Pharmaceuticals
Sell10b5-1 planAcadia Pharmaceuticals
ACAD
$297.9K
11,421 sh
$297.9K
Filed 06/29
Traded 06/26
- James Kihara
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 planAcadia Pharmaceuticals
ACAD
$297K
11,421 sh
$297K
Filed 06/26
Traded 06/26
- James Kihara
SellAcadia Pharmaceuticals
SellAcadia Pharmaceuticals
ACAD
$114.4K
5,401 sh
$114.4K
Filed 05/27
Traded 05/26
- James Kihara
Planned saleAcadia Pharmaceuticals
Planned saleAcadia Pharmaceuticals
ACAD
$114.4K
5,401 sh
$114.4K
Filed 05/26
Traded 05/26
- James Kihara
SellAcadia Pharmaceuticals
SellAcadia Pharmaceuticals
ACAD
$29K
1,332 sh
$29K
Filed 05/05
Traded 05/04